RxDoctor Payments Data

Gaorav Gupta

Radiation Oncology · Chapel Hill, NCNPI 1740416478

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 3 manufacturers reported payments, led by Johnson & Johnson at 48.4% of the total. 2025 is the largest year on record at $147, 5.1 times the $28 reported in 2023. That places this record below the midpoint for radiation oncology clinicians in NC, where the typical reported total is $329.

$302in general payments, 2019–2025

Across 3 payments — averaging $100.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$147
  • GE HealthCare$128
  • Ambu Inc.$28
$599,827in research payments, 2019–2025

Across 2 payments — averaging $299,913 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$600K

What the payments were for

  • Food & beverage$302100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson1$147
GE HealthCare1$128
Ambu Inc.1$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$302 in reported general payments places this provider in the 45th percentile of 199 radiation oncology providers in North Carolina.

See all radiation oncology providers in North Carolina

Medicare billing

Part B allowed, 2024
$20,353
Medicare patients
60
Services billed
237

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Chapel Hill

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →